Improving how people take breast-cancer and heart medicines
Part of Cancer, Skin clinical trials.
This trial tests an intervention to help improve how equitably people take their prescribed breast cancer hormone therapy and heart-related prevention medicines. It may help if you have had trouble taking these medications as directed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have been diagnosed with stage I to III breast cancer and were prescribed hormone (endocrine) therapy
- Be within 3 years after finishing early active breast cancer treatment (like surgery, chemo, or radiation; not counting HER2-targeted therapy)
- Be taking at least one medicine for heart protection, such as a blood pressure medicine (antihypertensive) or a cholesterol medicine (statin)
- Tell the study you sometimes do not take your breast cancer hormone medicine and/or your heart prevention medicine as you should
- No signs that your breast cancer has come back (no recurrence)
- Be able to participate in study tasks, understand the study, and give consent; you must speak English or Spanish
- Get your care at NewYork-Presbyterian through their system with a primary care doctor or cardiologist listed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help people with metastatic breast cancer take their endocrine therapy, CDK4/6 inhibitors, and heart-related medications as prescribed. If you sometimes miss doses of these medicines, you may be able to join.
This study tests a program to help people with metastatic breast cancer take their oral medications as prescribed. It uses a smartphone app to track and support medication adherence, which may improve treatment outcomes.
This trial tests a self-management program to reduce heart disease risks in women who have had breast cancer. It might help you if you have a heart condition and have finished active cancer treatment.
This study tests whether text message reminders help women with early-stage, hormone-sensitive breast cancer remember to take their daily cancer-prevention medication. The goal is to see if reminders improve how consistently women take their pills, which can help prevent cancer from coming back.
This trial tests a digital tool (a smartphone app) to help women and men with early breast cancer manage side effects from hormone therapy. The goal is to improve quality of life during treatment.
This study tests a set of practical support steps to help people with advanced cancer take their oral (by mouth) treatment medicines correctly. It may help improve adherence and reduce missed doses or appointments.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.